Anavex Life Sciences Corp (AVXL)

[nidan7500]

In the thousands of various trials that have been run thus far, is it common for naysaying by the scientific community?

If not, than the lack of it would not be unusual.

If I understand your question...it is not common for researchers to be openly/publicly critical of an others work, unless asked as part of a formal peer review process.

In this case I think the criticism is of the FDA AD trials process which would certainly seem justified, considering the resources used/cash/time and patient results.